Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

Journal of the National Cancer Institute

Volumn 98, Issue 8, 2006, Pages 535-544

  Andrieu, Nadine ^a   Goldgar, David E ^b   Easton, Douglas F ^c   Rookus, Matti ^d   Brohet, Richard ^d   Antoniou, Antonis C ^c   Peock, Susan ^c   Evans, Gareth ^e   Eccles, Diana ^f   Douglas, Fiona ^g   Noguès, Catherine ^h   Gauthier Villars, Marion ^a   Chompret, Agnès ⁱ   Van Leeuwen, Flora E ^d   Kluijt, Irma ^d   Benitez, Javier ^j   Arver, Brita ^k   Olah, Edith ^l   Chang Claude, Jenny ^m  

^a INSTITUT CURIE   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e Manchester Regional Genetics Service   (United Kingdom)

^f Wessex Clinical Genetics Service   (United Kingdom)

^g Northern Genetics Service   (United Kingdom)

^h CENTRE RENÉ HUGUENIN   (France)

ⁱ INSTITUT GUSTAVE ROUSSY   (France)

^j Centro Nacional de Investigaciones Oncológicas   (Spain)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL DIVISION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIPARA; MUTATIONAL ANALYSIS; PARITY; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; REGULATORY MECHANISM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; AGE; BREAST TUMOR; CLINICAL TRIAL; EUROPE; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PREGNANCY COMPLICATION; PROPORTIONAL HAZARDS MODEL; TIME; TUMOR SUPPRESSOR GENE;

ABORTION, INDUCED; ADULT; AGE FACTORS; BREAST FEEDING; BREAST NEOPLASMS; COHORT STUDIES; EUROPE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTERNATIONAL COOPERATION; MIDDLE AGED; MUTATION; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33646445514     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj132     Document Type: Article

References (41)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. Version 1.0. Lyon (France): IARC Press; 2001. IARC Cancer Base No. 5.
2. Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999;1:14-7.
3. Ponder BA. Cancer genetics. Nature 2001;411:336-41.
4. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
5. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56:265-71.
6. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
7. Begg CB. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 2002;94:1221-6.
8. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002;108:171-82.
9. Razandi M, Pedram A, Rosen EM, Levin ER. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 2004;24:5900-13.
10. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995;9:444-50.
11. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
12. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992;23:211-8.
13. Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncol Res 1999;11:169-78.
14. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 2004;25:741-8.
15. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
16. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187-95.
17. Beral V, Bull D, Doll R, Peto R, Reeves G. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83000 women with breast cancer from 16 countries. Lancet 2004;363: 1007-16.
18. Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res 2001;61: 5420-4.
19. Jernstrom H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet 1999;354:1846-50.
20. Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: Effects of reproductive history. Epidemiology 2002;13:255-61.
21. Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, et al. BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res 2003;5:R121-8.
22. Chang-Claude J, Becher H, Eby N, Bastert G, Wahrendorf J, Hamann U. Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 1997;123:272-9.
23. Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, et al. Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 1995;64: 394-8.
24. Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004;96:1094-8.
25. Goldgar D, Bonnardel C, Renard H, Yaqoubi O, The IBCCS Collaborators Group. The International BRCA1/2 Carrier Cohort Study: Purpose, rationale, and study design. Breast Cancer Res 2000;2:E10. Available at: http://breast-cancer-research.com/content/2/6/E010. [Last accessed: March 21, 2006.]
26. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 2005; 28:1-11.
27. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. JASA 1989;84:1074-8.
28. Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T. Breast cancer risk factors and age at diagnosis: An Icelandic cohort study. Int J Cancer 2002;98:604-8.
29. Hofferbert S, Worringen U, Backe J, Ruckert EM, White K, Faller H, et al. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Genet Couns 2000;11:127-46.
30. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000;355:2015-20.
31. van Asperen CJ, Brohet RM, Meijers-Heijboeer EJ, Hoogerbrugge N, Verhoef S, Vasen HFA, et al. Cancer risks in BRCA2 families: Estimates for sites other than breast and ovary. J Med Genet 2005;42:711-9.
32. Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ. Parity and breast cancer risk: Possible effect on age at diagnosis. Int J Cancer 1986; 37:21-5.
33. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9.
34. Beral V, Reeves G. Childbearing, oral contraceptive use, and breast cancer. Lancet 1993;341:1102.
35. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/ BRCA2 mutation carrier. Int J Cancer 2005;117:988-91.
36. Kelsey JL, Horn-Ross PL. Breast cancer: Magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993;15:7-16.
37. Albrektsen G, Heuch I, Kvale G. The short-term and long-term effect of a pregnancy on breast cancer risk: A prospective study of 802 457 parous Norwegian women. Br J Cancer 1995;72:480-4.
38. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005;11: 5175-80.
39. Mueller CR, Roskelley CD. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2003;5:45-52.
40. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, et al. Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 2000;60:5635-9.
41. Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast cancer. Breast J 2001;7: 278-91.